Using electronic medical record data to report laboratory adverse events

Despite the importance of adverse event (AE) reporting, AEs are under‐reported on clinical trials. We hypothesized that electronic medical record (EMR) data can ascertain laboratory‐based AEs more accurately than those ascertained manually. EMR data on 12 AEs for patients enrolled on two Children's Oncology Group (COG) trials at one institution were extracted, processed and graded. When compared to gold standard chart data, COG AE report sensitivity and positive predictive values (PPV) were 0–21·1% and 20–100%, respectively. EMR sensitivity and PPV were >98·2% for all AEs. These results demonstrate that EMR‐based AE ascertainment and grading substantially improves laboratory AE reporting accuracy.

[1]  Umit Topaloglu,et al.  An adverse event capture and management system for cancer studies , 2015, BMC Bioinformatics.

[2]  Stuart Lipsitz,et al.  The Reliability of Medical Record Review for Estimating Adverse Event Rates , 2002, Annals of Internal Medicine.

[3]  P. Dayan,et al.  Development, Evaluation and Implementation of Chief Complaint Groupings to Activate Data Collection , 2015, Applied Clinical Informatics.

[4]  Low interrater reliability in grading of rectal bleeding using National Cancer Institute Common Toxicity Criteria and Radiation Therapy Oncology Group Toxicity scales: a survey of radiation oncologists. , 2014, International journal of radiation oncology, biology, physics.

[5]  S. Raimondi,et al.  Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children’s Oncology Group trial AAML0531. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  R. Wasserman,et al.  Comparative Effectiveness Research Through a Collaborative Electronic Reporting Consortium , 2015, Pediatrics.

[7]  Sarah Schmiege,et al.  Comparative Effectiveness Research , 2013, Western journal of nursing research.

[8]  J. Marc Overhage,et al.  Using Natural Language Processing to Improve Accuracy of Automated Notifiable Disease Reporting , 2008, AMIA.

[9]  J. Pater,et al.  Factors affecting workload of cancer clinical trials: results of a multicenter study of the National Cancer Institute of Canada Clinical Trials Group. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  A. Neugut,et al.  Preliminary Development and Evaluation of an Algorithm to Identify Breast Cancer Chemotherapy Toxicities Using Electronic Medical Records and Administrative Data. , 2015, Journal of oncology practice.

[11]  Scott D Ramsey,et al.  A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program. , 2010, Journal of the National Cancer Institute.

[12]  A. Troxel,et al.  Accuracy of Adverse Event Ascertainment in Clinical Trials for Pediatric Acute Myeloid Leukemia. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  M. Samore,et al.  Combining Free Text and Structured Electronic Medical Record Entries to Detect Acute Respiratory Infections , 2010, PloS one.